Compound information
- Natural Products
- ZC3626755
- Molecular Formula
- C28H40N2O4S2
- Molecular Weight
- 532.24294976 g/mol
- Structure
-
- IUPAC Name
- benzyl N-[(1S)-1-[[[(2S)-2-(benzyloxycarbonylamino)-4-methyl-pentyl]disulfanyl]methyl]-3-methyl-butyl]carbamate
- InChI
- InChI=1S/C28H40N2O4S2/c1-21(2)15-25(29-27(31)33-17-23-11-7-5-8-12-23)19-35-36-20-26(16-22(3)4)30-28(32)34-18-24-13-9-6-10-14-24/h5-14,21-22,25-26H,15-20H2,1-4H3,(H,29,31)(H,30,32)/t25-,26-/m0/s1
- InChI Key
- AEWOICLODRFYKF-UIOOFZCWSA-N
- SMILES
- CC(C)C[C@@H](CSSC[C@H](CC(C)C)NC(=O)OCc1ccccc1)NC(=O)OCc1ccccc1
- Source
- ZINC000003850969
Warheads
- Carbamate
-
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 36 | Ring Count | 2 |
Heteroatom Count | 8 | Rotatable Bond Count | 15 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 76.66 Å2 | LogP | 6.631 |
LogS | -5.799 | LogD | 4.889 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.969 | Pgp substrate | 0.241 |
HIA | 0.969 | F20 % | 0.992 |
F30 % | 0.455 | Caco-2 | -4.907 |
MDCK | -4.717 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.083 | PPB | 97.69 |
VD | 0.977 | Fu | 2.061 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.95 | CYP1A2 substrate | 0.694 |
CYP2A6 substrate | 0.425 | CYP2B6 substrate | 0.666 |
CYP2C19 inhibitor | 0.961 | CYP2C19 substrate | 0.84 |
CYP2C8 substrate | 0.828 | CYP2C9 inhibitor | 0.984 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.19 |
CYP2D6 substrate | 0.949 | CYP2E1 substrate | 0.174 |
CYP3A4 inhibitor | 0.982 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.703 | CL | 5.924 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.012 | Hepatotoxicity | 0.999 |
Mutagenicity | 0.631 | Rat Oral Acute Toxicity | 0.064 |
FDAMDD | 0.545 | Skin Sensitization | 0.574 |
Carcinogenicity | 0.028 | Eye Corrosion | 0.004 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.085 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.38 | IGC50 | 5.071 |
LC50FM | 5.614 | LC50DM | 6.26 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.161 | NR-AR-LBD | 0.162 |
NR-AhR | 0.005 | NR-Aromatase | 0.078 |
NR-ER | 0.503 | NR-ER-LBD | 0.452 |
NR-PPAR-gamma | 0.245 | SR-ARE | 0.567 |
SR-ATAD5 | 0.642 | SR-HSE | 0.332 |
SR-MMP | 0.617 | SR-p53 | 0.422 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.